News
A trailblazing breast cancer researcher at the University of Washington has not received $1.8 million in promised funding ...
A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...
A new clinical trial shows the immunotherapy drug dostarlimab may eliminate the need for surgery and chemotherapy in certain ...
Australian researchers have discovered that a single mutation in the DNA sequence for a methylation enzyme dysregulates key ...
A new Stanford blood test detects cancer and tissue damage by analyzing rare RNA fragments in the blood. Stanford Medicine ...
Hayden Becker and his family distributed hundreds of BRCA mutation test kits to members of Park Avenue Synagogue.
The numbers for bowel cancer, the third-most-common type worldwide, are rising particularly fast (see chart). Compared with ...
As the luminary ceremony began and candlelit bags glowed in the dark, each carrying the name of a loved one, Zach felt ...
Australian researchers have discovered that a single mutation in the DNA sequence for a methylation enzyme dysregulates key ...
In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the ...
The O'Hern sisters helped each other fight breast cancer. Now they're walking in the 2025 Kentucky Oaks Survivors Parade at ...
The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results